Intensity Therapeutics
Organization
Based in
United States
Sources: sec.gov
Trials
A Biomarker Study of ATH434 in Participants With MSA
Phase 2, Completed, 10 people, May 18, 2023
Study of ATH434 in Participants with Multiple System Atrophy
Phase 2, Completed, 77 people, Nov 5, 2021
Collaborator, Phase 2, Status unknown, 90 people, Mar 4, 2021
Phase 1/2, Completed, 111 people, Feb 20, 2017
Sources: clinicaltrials.gov